Role of Proton Magnetic Resonance Spectroscopy in Differentiating Oligodendrogliomas from Astrocytomas

Preoperative differentiation of astrocytomas from oligodendrogliomas is clinically important, as oligodendrogliomas are more sensitive to chemotherapy. The purpose of this study was to assess the role of proton magnetic resonance spectroscopy in distinguishing astrocytomas from oligodendrogliomas.

• Publication year

  2010

• Venue

  Journal of Neuroimaging

• Publication date

  2010-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1552-6569.2008.00307.xPMID 19021846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Perfusion Magnetic Resonance Imaging Predicts Patient Outcome as an Adjunct to Histopathology: A Second Reference Standard in the Surgical and Nonsurgical Treatment of Low-grade Gliomas

  2006cited by this paper
• Perfusion Magnetic Resonance Imaging Predicts Patient Outcome as an Adjunct to Histopathology: A Second Reference Standard in the Surgical and Nonsurgical Treatment of Low-grade Gliomas.

  2006cited by this paper
• In vivo detection of brain glycine with echo‐time‐averaged 1H magnetic resonance spectroscopy at 4.0 T

  2006cited by this paper
• Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.

  2006cited by this paper
• Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation

  2005cited by this paper
• Strategy for the spectral filtering of myo‐inositol and other strongly coupled spins

  2004cited by this paper
• Proton magnetic resonance spectroscopy (1H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization

  2003cited by this paper
• Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging

  2003cited by this paper
• Magnetic resonance spectroscopy of brain hemangiopericytomas: high myoinositol concentrations and discrimination from meningiomas.

  2001cited by this paper
• Chemotherapy for the treatment of oligodendroglial tumors.

  2001cited by this paper
• Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligo-astrocytomas.

  2001cited by this paper
• Proton NMR chemical shifts and coupling constants for brain metabolites

  2000cited by this paper
• Correlation of myo-inositol levels and grading of cerebral astrocytomas.

  2000cited by this paper
• Clinical impact of MR spectroscopy when MR imaging is indeterminate for pediatric brain tumors.

  1999cited by this paper
• Tumour phospholipid metabolism

  1999cited by this paper
• Magnetic resonance spectroscopy study of low grade extra and intracerebral human neoplasms.

  1998cited by this paper
• A new multiple quantum filter design procedure for use on strongly coupled spin systems found in vivo: Its application to glutamate

  1998cited by this paper
• Signalling through the lipid products of phosphoinositide-3-OH kinase

  1997cited by this paper
• Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.

  1996cited by this paper
• Glioma invasionin vitro: regulation by matrix metalloprotease-2 and protein kinase C

  1996cited by this paper
• Spectroscopic imaging of human brain glutamate by water‐suppressed J‐refocused coherence transfer at 4.1 T

  1996cited by this paper
• Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.

  1996cited by this paper
• Histopathology, classification, and grading of gliomas

  1995cited by this paper
• In Vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi‐dimensional classification

  1995cited by this paper
• Localized two‐dimensional shift correlated spectroscopy in humans at 2 Tesla

  1994cited by this paper
• Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.

  1994cited by this paper
• Multinuclear NMR studies on the energy metabolism of glial and neuronal cells.

  1993cited by this paper
• The New WHO Classification of Brain Tumours

  1993cited by this paper
• Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types

  1993cited by this paper
• Osmoregulation of Na(+)-inositol cotransporter activity and mRNA levels in brain glial cells.

  1992cited by this paper
• High‐Resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms

  1992cited by this paper
• Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; Myo‐inositol and related metabolites

  1991cited by this paper
• Gliomas: classification with MR imaging.

  1990cited by this paper
• High‐field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy

  1989cited by this paper
• Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo.

  1984cited by this paper

• Optimized Long‐TE 1H sLASER MR Spectroscopic Imaging at 3T for Separate Quantification of Glutamate and Glutamine in Glioma

  2025cites this paper
• Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI

  2023cites this paper
• Spatial metabolic heterogeneity of oligodendrogliomas at single-cell resolution

  2023cites this paper
• Challenges and opportunities for advanced neuroimaging of glioblastoma

  2022cites this paper
• Standard clinical approaches and emerging modalities for glioblastoma imaging

  2022cites this paper
• In vivo brain MR spectroscopy in gliomas: clinical and pre-clinical chances

  2022cites this paper
• Emerging MR Imaging and Spectroscopic Methods to Study Brain Tumor Metabolism

  2022cites this paper
• Metabolic and physiologic magnetic resonance imaging in distinguishing true progression from pseudoprogression in patients with glioblastoma

  2022cites this paper
• SWI by 7T MR Imaging for the Microscopic Imaging Diagnosis of Astrocytic and Oligodendroglial Tumors

  2022cites this paper
• Investigation of metabolic kinetics in different brain regions of awake rats using the [ 1 H-13 C]-

  2021cites this paper
• Physiological Imaging Methods for Evaluating Response to Immunotherapies in Glioblastomas

  2021cites this paper
• Emerging MRI Techniques to Redefine Treatment Response in Patients With Glioblastoma

  2020cites this paper
• Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas

  2020cites this paper
• Glutamine Metabolism in Brain Tumors

  2019cites this paper
• Surgical management of pediatric oligodendroglioma

  2019cites this paper
• Advanced Multiparametric Imaging for Response Assessment to Tumor-Treating Fields in Patients with Glioblastoma

  2019cites this paper
• Three‐dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma

  2018cites this paper
• Tumor-Specific Approach: Oligodendroglioma (IDH1 Mutated, 1p/19q Deleted)

  2017cites this paper
• Glutaminolysis: A Hallmark of Cancer Metabolism.

  2017cites this paper
• Non-invasive metabolic imaging of brain tumours in the era of precision medicine

  2016cites this paper
• Magnetic Resonance (MR) Metabolic Imaging in Glioma

  2015cites this paper
• Characterization of metabolites in infiltrating gliomas using ex vivo 1H high-resolution magic angle spinning spectroscopy

  2014cites this paper
• Characterization of metabolites in infiltrating gliomas using <i>ex vivo</i> ¹H highâ•’resolution magic angle spinning spectroscopy

  2014cites this paper
• 3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature

  2013cites this paper
• Imaging and spectroscopy at 9.4 Tesla: first results on patients and volunteers

  2013cites this paper
• Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.

  2013cites this paper
• Glutamate and glutamine: a review of in vivo MRS in the human brain

  2013cites this paper
• Differentiation between Oligodendroglioma Genotypes Using Dynamic Susceptibility Contrast Perfusion-Weighted Imaging and Proton MR Spectroscopy

  2013cites this paper
• Advanced MR Imaging Techniques in the Evaluation of Nonenhancing Gliomas: Perfusion-Weighted Imaging Compared with Proton Magnetic Resonance Spectroscopy and Tumor Grade

  2013cites this paper
• Proton Magnetic Resonance Spectroscopy in Differentiating Glioblastomas From Primary Cerebral Lymphomas and Brain Metastases

  2010cites this paper
• Current Awareness in NMR in Biomedicine

  2010cites this paper